Previous Article | Next Article 
The Journal of Neuroscience, October 1, 1999, 19(19):8674-8684
Decreased G-Protein-Mediated Regulation and Shift in Calcium
Channel Types with Age in Hippocampal Cultures
Eric M.
Blalock,
Nada M.
Porter, and
Philip W.
Landfield
Department of Pharmacology, College of Medicine, University of
Kentucky, Lexington, Kentucky 40536
 |
ABSTRACT |
The membrane density of L-type voltage-sensitive
Ca2+ channels (L-VSCCs) of rat hippocampal neurons
increases over age [days in vitro (DIV)] in long-term
primary cultures, apparently contributing both to spontaneous cell
death and to enhanced excitotoxic vulnerability. Similar increases in
L-VSCCs occur during brain aging in vivo in rat and
rabbit hippocampal neurons. However, unraveling both the molecular
basis and the functional implications of these age changes in VSCC
density will require determining whether the other types of
high-threshold VSCCs (e.g., N, P/Q, and R) also exhibit altered density
and/or changes in regulation, for example, by the important
G-protein-coupled, membrane-delimited inhibitory pathway. These
possibilities were tested here in long-term hippocampal cultures.
Pharmacologically defined whole-cell currents were corrected for cell
size differences over age by normalization with whole-cell capacitance.
The Ca2+ channel current density (picoamperes per
picofarad), mediated by each Ca2+ channel type
studied here (L, N, and a combined P/Q + R component), increased
through 7 DIV. Thereafter, however, only L-type current density
continued to increase, at least through 21 DIV. Concurrently, pertussis
toxin-sensitive G-protein-coupled inhibition of non-L-type Ca2+ channel current induced by the
GABAB receptor agonist baclofen or by guanosine
5'-3-O-(thio)triphosphate declined dramatically with age in culture. Thus, the present studies identify selective and
novel parallel mechanisms for the time-dependent alteration of
Ca2+ influx, which could importantly influence
function and vulnerability during development and/or aging.
Key words:
hippocampal neurons; aging; cell culture; calcium channel
currents; L-type channels; N-type channels; baclofen; G-protein-mediated inhibition
 |
INTRODUCTION |
A number of studies of neurons
during the first days or weeks of age in vitro or in
vivo have found that age-dependent changes in voltage-sensitive
Ca2+ channels (VSCCs) are closely
associated with the onset of several critical developmental functions.
These functions include cellular differentiation (Spitzer et al.,
1994
), neurite outgrowth (Mattson and Kater, 1987
; Rusanescu et al.,
1995
; Schmid and Guenther, 1999
), synaptogenesis (Basarsky et al.,
1994
; Scholz and Miller, 1995
), electrophysiological maturity (Groul et
al., 1992
), and patterns of neuronal intrinsic activity (Turrigiano et
al., 1994
, 1995
).
In addition to the Ca2+ dependence of
multiple developmental functions, however, neuronal excitotoxicity and
other forms of cell death are strongly
Ca2+-dependent (Olney, 1986
; Choi, 1988
;
Abele et al., 1990
; Dubinsky and Rothman, 1991
; Tymianski et al., 1993
;
Lipton, 1994
; Ankarcrona et al., 1995
). Furthermore, it has become
increasingly evident that the susceptibility of primary cultured
neurons to Ca2+-mediated excitotoxic
insult rises dramatically with age in culture, particularly between 1 and 3 weeks in culture (Choi, 1987
, 1988
; Frandsen and Schousboe, 1990
;
Regan and Choi, 1991
; McDonald et al., 1997
; Adamec et al., 1998
).
However, in contrast to the extensive studies of VSCCs and
developmental functions in younger neurons, little is known about how
age-dependent alterations in VSCCs may contribute to the enhanced vulnerability of more mature neurons. Although excitotoxicity is often
attributed to Ca2+ influx through NMDA
receptors (see above), and NMDA currents and binding proteins change
with age in culture (Mattson et al., 1991
; Ujihara and Albuquerque,
1992
; Xia et al., 1995
), there is also substantial evidence that VSCCs
play some role in glutamate excitotoxicity (Weiss et al., 1990
; Lipton,
1994
; Geddes et al., 1997
; Kimura et al., 1998
; Roy et al., 1998
).
Moreover, during normal glutamatergic synaptic transmission, the
resulting postsynaptic depolarization also strongly activates
Ca2+ influx through VSCCs (Brown and
Jaffe, 1994
; Magee and Johnston, 1995
; Bollmann et al., 1998
).
Thus, it seems possible that VSCCs could be involved in enhanced
excitotoxic vulnerability with age in culture, which is in part
supported by our recent finding that L-type VSCCs (L-VSCCs) in
hippocampal neurons exhibit a substantial age-dependent increase over
28 d in vitro (DIV). Over the same period spontaneous
cell death can be blocked by nimodipine, an L-VSCC antagonist (Porter et al., 1997
), and L-type VSCCs contribute increasingly to both glutamate-induced Ca2+ transients and
excitotoxicity (Geddes et al., 1997
; Thibault et al., 1997
).
Altered VSCCs could be relevant to changing function or vulnerability
during normal brain aging as well. Although various aspects of altered
Ca2+ homeostasis appear to play important
roles in brain aging and/or dementia (for review, see Disterhoft et
al., 1994
; Khatchaturian, 1994
; Thibault et al., 1998
; Verkhratsky and
Toescu, 1998
), increased L-VSCC currents, potentials, or single-channel
densities are seen in hippocampal neurons of aging rats and rabbits
(Landfield et al., 1989
; Moyer et al., 1992
; Disterhoft et al., 1994
;
Campbell et al., 1996
). However, it remains unknown whether age changes in VSCC density either in vivo or in vitro are
selective for the L-type VSCC or instead also occur in other types of
high-threshold VSCCs (N, P/Q, and R types).
Apart from changes in channel density,
Ca2+ influx through N- and P/Q-type VSCCs
is also strongly and negatively regulated by a membrane-delimited,
G-protein-coupled inhibitory pathway activated by several
neurotransmitters (Holz et al., 1986
; Hescheler et al., 1987
; Bean,
1989
; Cox and Dunlap, 1992
; Delcour and Tsien, 1993
; Hille, 1994
;
Dolphin, 1995
; Currie and Fox, 1997
; Zamponi and Snutch, 1998
). Because
synaptic transmission is consistently impaired with aging (Barnes and
McNaughton, 1980
; Landfield et al., 1986
; Rose et al., 1986
;
Bickford-Wimer et al., 1988
; Hoffer et al., 1988
; Barnes, 1994
;
Geinisman et al., 1994
), as is neurotransmitter-activated G-protein
coupling to non-membrane-delimited second messenger systems (Wang et
al., 1992
; Roth et al., 1995
; Cowburn et al., 1996
), it seems possible
that non-L-VSCC regulation by neurotransmitters could also be affected
by age. However, the membrane-delimited pathway has not yet been
studied extensively in relation to age either in vitro or
in vivo.
Thus it clearly seems essential for a comprehensive view of the
molecular mechanisms and functional implications of age-dependent alterations in VSCC density to test the hypothesis that changes in the
density and/or regulation of non-L-VSCCs occur in parallel to the
age-dependent density changes seen in L-type VSCCs. The present studies
examined this hypothesis in long-term primary cultures.
 |
MATERIALS AND METHODS |
Cell culture. Primary cultures of hippocampal cells
were established using a modification of the procedure of Banker and
Cowan (1977)
. The day before plating, plastic culture dishes containing Thermanox plastic coverslips (Nunc, Naperville, IL) were treated with
poly-L-lysine (100 µg/ml). On the day of plating,
pregnant female Sprague Dawley rats were killed using
CO2 and cervical dislocation, and fetal
(embryonic day 18) rats were obtained by cesarean section, in
accordance with protocols approved by the institutional animal care
committee. The embryonic hippocampi were dissected and incubated for 10 min in an enzymatic solution (0.25% trypsin and 1 mM EDTA
in HBSS), washed three times in minimal essential medium (MEM),
and triturated to dissociate cells. One milliliter of the resulting
cell suspension (diluted to 3-5 × 105 cells/ml) and 1 ml of supplemented MEM
(SMEM; MEM with 10% fetal bovine serum and 10% horse serum) then were
added to poly-L-lysine-coated dishes and coverslips.
Cultures were placed in an incubator (5% CO2,
36°C) overnight, and the following day half the culture medium was
replaced with 1 ml of SMEM containing 10% horse serum but no fetal
bovine serum (SMEM/H). To prevent glial proliferation, at 5 DIV 1 ml of
culture media was replaced with 1 ml of SMEM/H supplemented with 15 µg/ml 5-flouro-2'-deoxyuridine (antimitotic) and 35 µg/ml uridine
(to support RNA synthesis).
Age comparisons were performed in sister cultures allowed to age for
different durations up to 21 DIV. To obtain a sufficient number of
cells per age point and to ensure that results were not specific for a
given culture, the experiments were repeated in three different culture
platings. No significant differences in average current were found
among the three different culture platings at any age point (two-way
ANOVA, p < 0.6 for plating; p < 0.001 for age of culture), and the age-matched data from the different
platings were, therefore, pooled for further analysis (total cells = 76; 3 DIV, n = 7; 7 DIV, n = 24; 14 DIV, n = 23; 21 DIV, n = 21) .
Electrophysiological recording. A modified version of the
"coverslip" method of Randall and Tsien (1995)
was used for
recording procedures. A small (~4 × 4 mm) piece of the plastic
coverslip was cut out using sterile procedures, transferred to a bath
perfusion chamber (Warner Instruments, Hamden, CT), and discarded after recording. The remaining coverslip was returned to the incubator. This
method allowed us to record multiple cells from a single culture dish
each day. The whole-cell bath solution contained (in mM):
111 NaCl, 5 BaCl2, 5 CsCl, 2 MgCl2, 10 glucose, 10 HEPES, 20 TEA-Cl, and 0.001 tetrodotoxin (TTX). The pH was adjusted to 7.35 with NaOH; the
osmolarity was adjusted to 330 mOsm with sucrose. The pipette solution
contained (in mM): 145 methanesulfonic acid, 10 HEPES, 2.34 MgCl2, 10 BAPTA, 5 MgATP, 13 TEA-Cl, and 0.1 leupeptin. The pH was adjusted to 7.35 with CsOH, and the osmolarity
was adjusted to 320 mOsm with distilled
H2O. Pipette solution was aliquoted and frozen
(
20°C) for later use.
All recordings were performed at room temperature (21-22°C).
Electrodes were pulled from Fisher Scientific (Houston, TX)
microhematocrit nonheparinized glass capillaries (catalog #02-668-68)
with a Flaming-Brown horizontal puller (Sutter Instruments, Novato,
CA). Electrodes were coated with polystyrene Q-dope (GC Electronics,
Rockford, IL) and had resistances averaging ~2.2 M
. The junction
potential was nulled with the electrode in the bath, and the whole-cell patch-clamp recording configuration was established according to
standard methods (Hamill et al., 1981
). Cells were voltage-clamped at
70 mV with an Axopatch 200 patch-clamp amplifier (Axon Instruments, Foster City, CA). After allowing 5-10 min for whole-cell current to
stabilize, command voltage steps were administered, and the resulting
current records were digitized and stored using pClamp (6.03) software.
Experimental protocols. In a study of whole-cell current
change with age, cell size is a critical control issue. Therefore, whole-cell current amplitude was normalized throughout by dividing by
whole-cell capacitance to yield current density (picoamperes per
picofarad). Cell capacitance and series resistance were measured at the
start of each recording in each cell. Passive membrane current was
evoked with small, hyperpolarizing (
5 mV) voltage steps from a
holding potential of
70 mV, and the current records were
low-pass-filtered at 10 kHz and digitized at 91 kHz to allow accurate
resolution of the decay of the capacitive current. It is well
recognized that whole-cell capacitance is directly proportional to cell
size (membrane surface area) (Cahalan and Neher, 1992
). However,
because dendritically ramified hippocampal neurons are not isopotential
and can often have decay time constants that are best fit by multiple
exponentials (Johnston and Brown, 1983
; Spruston et al., 1993
;
Carnevale et al., 1997
), we used the method of integrating the area
under the curve of the capacitive transient to estimate whole-cell
capacitance (Ulrich et al., 1994
; Kang et al., 1996
; Mathes, 1998
).
Series resistance was estimated from the instantaneous peak onset
current. Active current records were low-pass-filtered at 2 kHz,
digitized at 3.64 kHz, and leak subtracted using a P/
5 protocol.
The same current-voltage (I-V) protocols were
performed on each neuron. Cells were held at 70 mV, and successively
less negative command potentials (150 msec duration) were applied in 10 mV increments every 45 sec. After determining the voltage at which
maximal current was generated, that potential (+10 to +20 mV) was
applied every 30 sec during the application of pharmacological agents.
A second I-V curve was then recorded to determine whether a
treatment had shifted the voltage dependence. Cells with <500
M
whole-cell resistance were discarded. Series resistances
(SRs) for recorded cells averaged ~7.5
M
, which resulted in only minor voltage distortions. Series
resistance was not compensated, because our own observations, as well
as those of others (Randall and Tsien, 1995
), have consistently indicated that at these current amplitudes there is no apparent difference in whole-cell Ca2+ channel
current amplitude or kinetics before or after SR compensation.
To help distinguish between the more rapidly inactivating and more
slowly inactivating current types, three different components of the
whole-cell current were measured during command voltage steps: (1)
average step current (the integral of the step current divided by the
step duration); (2) peak current (initial maximal inward current during
the step); and (3) late current (10 msec before the end of the step).
For simplicity, average step current is not illustrated throughout,
although it should be noted that its amplitudes and patterns were
generally intermediate between late and peak current. As noted above,
each component was normalized for differences in cell size within and
across ages by transformation to current density (picoamperes per
picofarad) (dividing each current measure by the whole-cell capacitance
for that cell).
Hippocampal neurons in vivo and in vitro exhibit
a long-lasting tail-like, or repolarization,
Ca2+ (or
Ba2+) channel current (Campbell et al.,
1996
; Porter et al., 1997
). This repolarization current may be
attributable to openings of VSCCs seen at the single-channel level on
repolarization (Fisher et al., 1990
; Slesinger and Lansman, 1991
; Forti
and Pietrobon, 1993
; Thibault et al., 1993
; Kavalali and Plummer, 1994
;
Thibault and Landfield, 1996
), because these openings can be extremely frequent at physiological concentrations of divalent charge carrier (Thibault et al., 1993
). However, another possibility is that this
current could arise from unclamped Ca2+
channels in small basilar dendrites (Johnston and Brown, 1983
; Armstrong and Gilly, 1992
; Spruston et al., 1993
; Carnevale et al.,
1997
). Nevertheless, because of the long duration of the tails, such
sites would have to be extremely distant electrotonically (i.e., slow
currents are less affected by space-clamp problems). We have also ruled
out the possibility that the tail currents arise from poor space clamp
of the large apical dendritic tree. Experiments in which the major
apical dendrites of cultured neurons were severed or patch-clamped
simultaneously with the soma did not change the shape or proportional
amplitude of tail current. Furthermore, current-clamp recordings from
the apical dendrites of somatically voltage-clamped neurons showed
that, during steps to command potentials the apical dendrite was very
well clamped (Thibault et al., 1995
), as might be anticipated from its
large diameter and relative electrotonic proximity (Johnston and Brown, 1983
; Spruston et al., 1993
; Carnevale et al., 1997
). Finally, the long
tail can be inactivated separately from the main command step current
without altering the step current amplitude or shape (Mazzanti and
Landfield, 1994
). However, because of the ambiguity of its origin, tail
current was not analyzed or illustrated in the present study.
Drug application. Drugs were applied using "weeper"
perfusion pipettes (5-10 µm tip glass pipettes filled with
appropriate drug concentrations and positioned two somal diameters from
the cell) or by bath perfusion, as described in Results. Saturating concentrations of nimodipine (10 µM in 0.1% EtOH) and
-conotoxin GVIA (
-CTX; 1 µM in 0.1 mg/ml cytochrome
c) were used to selectively inhibit L- and N-type currents,
respectively. To control for vehicle effects both EtOH and cytochrome
c were present in all solutions. The
Na+ channel blocker TTX (1 µM) was included in the weeper solution but not
the bath recording solution to detect obstructed perfusion pipettes.
Clogged weepers were identified by the emergence of a fast
Na+ spike current in the record.
Data analysis. SigmaStat (version 2.0) software was used for
statistical analysis and specific tests are described in Results. Nonlinear fits were carried out using the TableCurve 2D (version 2.03)
curve-fitting software. Data from nimodipine concentration-response experiments were fit by the following equation (Taylor and Insel, 1990
):
where a is Imax (the
maximum amount of current inhibited), b is
IC50, and c is the slope of
the response over its linear range. To determine whether fitted
parameters differed significantly with treatment or age, they were
compared using the z test (Armitage and Berry, 1990
) as
follows:
where X and µ are the fitted parameters to be
compared, SEX is the SE for X, and
SEµ is the standard error for µ. If
z < 2, then the compared parameters were not
considered significantly different.
Chemicals. Baclofen-(±), nimodipine, and
-CTX were
obtained from Research Biochemicals (Natick, MA). All other chemicals were obtained from Sigma (St. Louis, MO). Nimodipine was stored in
opaque containers at
20°C as a 10 mM stock solution in
100% EtOH. Baclofen was dissolved in distilled
H2O for a stock solution of 100 mM
and stored at 4°C.
-CTx was prepared as a 1 mM stock in distilled H2O with an additional 100 mg/ml
cytochrome c, aliquoted, and stored at
20°C.
 |
RESULTS |
Increase in total current and total current density over age
in culture
A highly significant increase in total whole-cell current
amplitude occurred with age in culture (Fig.
1A; p < 0.001, ANOVA). The I-V experiments (Fig.
1B) indicated that voltage dependence and the step
generating maximum inward current (usually +10 or +20 mV) remained
relatively stable with culture age. However, much of this age effect
can be attributed to changes in cell size. Neurons and their processes
grow substantially over time in culture (Yang et al., 1993
; Porter et
al., 1997
), which, if channel density remains constant, increases
whole-cell current amplitude. Neuronal growth with age was also seen in
the present studies, as indicated by a significant age-dependent
increase in total cell capacitance in these cultures (data not shown;
p < 0.01, ANOVA).

View larger version (16K):
[in this window]
[in a new window]
|
Figure 1.
Ca2+ channel current
increase over age in culture. A, Whole-cell current
averaged for each age group (n = 7, 24, 23, and 21 for 3, 7, 14, and 21 DIV, respectively) revealed a dramatic increase in
peak current amplitude with age in culture. B,
I-V experiments showed that maximum inward current was
generated by similar voltage steps in all ages tested.
C, Capacitance-normalized current revealed a large
increase in density between 3 and 7 DIV with a trend toward increasing
current density at later time points.
|
|
As noted, however, differences in cell size were corrected throughout
by transforming the amplitudes to current density values (see Materials
and Methods). The increase in total normalized current density with age
was also highly significant (p < 0.01) but
showed a substantially different pattern from noncorrected current.
Total current density increased rapidly between days 3 and 7 followed
by a more slowly rising phase at later ages (Fig. 1C),
similar to that seen by Porter et al. (1997)
.
Pharmacological dissection of Ca2+
channel current
The pharmacological dissection of specific types of
Ca2+ channel current is well characterized
and has to date identified at least five distinct types of
voltage-sensitive Ca2+ channels, each of
which has been linked to one or more unique
1
subunit genes. These types are commonly termed "L" (for
long-lasting), "N" (for neuronal), "T" (for transient),
"P/Q" (for Purkinje and Q for a related form), and "R" (for
resistant) (Tsien et al., 1988
; Llinás et al., 1989
; Regan et
al., 1991
; Cox and Dunlap, 1992
; Zhang et al., 1993
; Bargas et al.,
1994
; Birnbaumer et al., 1994
; Boland et al., 1994
; Eliot and Johnston,
1994
; Wu and Saggau, 1994
; Catterall, 1995
; Ishibashi et al., 1995
;
Lorenzon and Foehring, 1995
; Randall and Tsien, 1995
).
In the present studies, saturating concentrations of the selective L-
and N-type Ca2+ channel blockers (10 µM nimodipine and 1 µM
-CTX,
respectively) were used to define L-type and N-type current. The
remaining current ("residual") that was insensitive to either
blocker was a composite presumably comprising P/Q and R types
(low-voltage-activated T-type current was largely excluded by our
voltage protocols). A response was considered stable in the presence of
a particular blocker when three successive depolarizations (interpulse
interval, 30 sec) resulted in current traces that essentially
overlapped. Whole-cell Ca2+ current was
measured sequentially after exposure to vehicle alone, after exposure
to vehicle plus nimodipine, and after exposure to vehicle and
nimodipine plus
-CTX. Typically,
-CTX required 90 sec exposure to
give stable inhibition, whereas nimodipine acted more rapidly (<30
sec). Three waveforms were averaged at each measured time point and
treated as a single current record for analysis.
Selectivity of nimodipine and
-CTX
Several studies have indicated that at high concentrations and in
certain cell types dihydropyridines can inhibit some
-CTX-sensitive current and, conversely,
-CTX can inhibit some
dihydropyridine-sensitive current (Regan et al., 1991
; Swandulla et
al., 1991
; Williams et al., 1992
; Zhang et al., 1993
; Diochet et al.,
1995
). To determine whether the blockers were selective and
nonoverlapping in the present studies, drug presentation was reversed
in separate groups of 21 DIV neurons. Nimodipine- and
-CTX-sensitive
currents were converted to a fraction of the total current. Nimodipine-
and
-CTX-sensitive current contributed ~40 and ~20% of average
step current, respectively, regardless of the presentation order of the
blockers (Fig. 2). Therefore, the two
Ca2+ channel blockers did not share a
common site of inhibition in this preparation.

View larger version (28K):
[in this window]
[in a new window]
|
Figure 2.
-CTX and nimodipine inhibited nonoverlapping
components of the current record. The fraction of mean
Ca2+ channel current inhibited by nimodipine
(Nim; 10 µM) and -CTX
(CTX; 1 µM) was unchanged by switching the
order of drug application from nimodipine first to -CTX first.
Two-Way ANOVA on repeated measures (RM), p < 0.01 for drug type; p > 0.5 for both
presentation order and interaction.
|
|
Shifts in Ca2+ channel current composition with
age in culture
Total whole-cell current at maximally activating voltages
increased more than eightfold between 3 and 21 DIV. Each of the uncorrected current-type components of the whole-cell current (e.g.,
L-, N-, and composite P/Q + R-type current) increased substantially and
persistently throughout the age range examined (Fig.
3A). However, as described
below, increases in current density were considerably more type- and
age-selective (Fig. 3B).

View larger version (36K):
[in this window]
[in a new window]
|
Figure 3.
Pharmacological dissection of whole-cell
Ca2+ channel current: a different profile of
functional Ca2+ channel current types with age
in culture. A, Averaged current records of cells aged 3, 7, 14, and 21 DIV recorded in vehicle (0.1% EtOH and 0.1 mg/ml
cytochrome c), after the addition of 10 µM
nimodipine, and after the further addition of 1 µM
-conotoxin GVIA. B, Capacitance-normalized
nimodipine-sensitive current (L), -conotoxin
GVIA-sensitive current (N), and current
unaffected by these blockers (P/Q + R)
revealed different age-dependent profiles at peak (left
panel) and late (right panel)
portions of the current record.
|
|
Peak current density
At 3 DIV, N-, L-, and P/Q + R-type currents contributed
approximately equally to peak current density (Fig. 3B,
left). However, P/Q + R-type current density in the peak
measure increased dramatically between 3 and 7 DIV relative to N- and
L-type current density and thereafter remained relatively stable and
the dominant component of peak current density. N-and L-type peak
current densities also tended to rise between 3 and 7 DIV, but this
effect was not statistically significant (two-way ANOVA). After 7 DIV,
these components of the peak also remained relatively stable.
Late current density
The slowly inactivating late components exhibited markedly
different profiles relative to peak density measures (Fig.
3B, right). The three late components increased
significantly between 3 and 7 DIV, with the P/Q + R and L types
increasing somewhat more than the N type. After 7 DIV, the N- and P/Q + R-type late current densities remained relatively stable, increasing
only ~10-20%. However, the L-type contribution to the late current diverged substantially from the other two components, particularly after 14 DIV. By 21 DIV L-type current density was nearly double its 7 DIV value (p < 0.05, two-way ANOVA). Thus,
after 7 DIV, the late L-type current was the only current density
component that exhibited a clear, statistically significant increase.
Nimodipine sensitivity over age in culture
It is possible that the apparent increase in L-type current seen
over age in culture could reflect, in part, an increase in nimodipine
sensitivity rather than amount of L-type current (e.g., the 10 µM nimodipine concentration might not be saturating at earlier age points). To test this, we performed concentration-response experiments in which six or seven cells per age group (3, 7, 14, and 21 DIV) were exposed sequentially to 0.001, 0.01, 0.1, 1, and 10 µM nimodipine in a constant 0.1% EtOH bath solution.
These studies confirmed the approximately two-fold age-dependent
increase in maximal current density inhibited by nimodipine (Imax) and, in addition, revealed no
age-dependent change in nimodipine sensitivity
(IC50) (Fig.
4, Table
1). Furthermore, the 10 µM nimodipine concentration was saturating at
all ages. The increase in Imax values
was significant between 3 and 7 as well as 14 and 21 DIV (Table 1),
whereas IC50 values did not differ
significantly at any age point.

View larger version (27K):
[in this window]
[in a new window]
|
Figure 4.
Age in culture did not alter concentration
dependence of nimodipine inhibition of Ca2+ channel
current. Semilog concentration-response graph is shown for six or
seven cells per age group exposed to control and five concentrations of
nimodipine. Nimodipine-sensitive late current density is plotted as a
function of the log of nimodipine concentration. Nonlinear fits (see
Materials and Methods) and means ± SEM for each age group
are plotted. Resulting fit parameters are shown in Table 1.
|
|
G-protein-coupled inhibition of Ca2+
channel current
Baclofen, a selective GABAB agonist, was
used to determine whether neurotransmitter-mediated G-protein
inhibition of Ca2+ channels also changed
with age in culture during the relative decrease in G-protein-sensitive
current (N and P/Q + R type). In these studies, GTP (0.5 mM; Tris salt) was added to the intracellular recording solution.
Although a number of neurotransmitters inhibit
Ca2+ channel currents through the
membrane-delimited pathway in brain neurons, inhibition by the
GABAB receptor is particularly pronounced and well characterized in hippocampus (Dutar and Nicoll, 1988
; Hirata et
al., 1995
; Frank et al., 1996
). However, to confirm that baclofen inhibition was Gi/o-protein-mediated (Hescheler
et al., 1987
; Wickman and Clapham, 1995
) in our preparation, we
examined the effects of pertussis toxin (PTX), a selective,
irreversible blocker of Gi/o (Gilman, 1987
).
Sister cultures (7-14 DIV) were incubated overnight in PTX (0.1 mg/ml)
or BSA (0.1 mg/ml). PTX pretreatment fully blocked baclofen-mediated
inhibition (Fig. 5A): baclofen inhibited 34.1± 1.9% of peak current in BSA-pretreated dishes (n = 7) and 1.2 ± 1.5% of peak current in
PTX-pretreated dishes (n = 7). A two-way ANOVA for
repeated measures showed a significant main effect of baclofen exposure
(p < 0.001), as well as a significant interaction between PTX and baclofen exposure (p < 0.005). Of interest was the observation that
Ca2+ channel current amplitude after 24 hr
PTX exposure but before baclofen application was not different in PTX-
and BSA-pretreated dishes. Thus, these results confirm
Gi/o mediation and also indicate that
Gi/o proteins do not maintain tonic inhibition of
Ca2+ channel current in these neurons
(Zhang et al., 1996
).

View larger version (24K):
[in this window]
[in a new window]
|
Figure 5.
Baclofen-mediated inhibition of current through
G-protein-dependent mechanisms. A, Cells treated 24 hr
with 0.1 mg/ml BSA (n = 7) showed normal response
to baclofen. Sister cultures treated 24 hr with 0.1 mg/ml PTX
(n = 6) failed to respond to baclofen. Two-way
ANOVA RM: baclofen, p < 0.05; PTX,
p > 0.1; interaction, p < 0.05) B, Time course of percentage-normalized responses.
In control cells ( ) baclofen inhibition was reversible by wash;
Ca2+ channel current in PTX-treated cells ( ) was
not significantly altered by baclofen, and Ca2+
channel current in cells pretreated with nimodipine ( )
(n = 6) was significantly inhibited
(p < 0.001, paired t test)
to a relatively greater degree than control cells.
|
|
To confirm the selectivity of this inhibitory pathway for non-L-type
currents, channel type selectivity of G-protein-coupled inhibition was
also tested in this preparation. Cells aged 6 DIV were pretreated
either with vehicle or 10 µM nimodipine for 5 min before
recording. After stable current was recorded (150 msec voltage steps
from
70 to +10 mV applied every 30 sec), baclofen (100 µM) was perfused onto the cell, and postbaclofen current was recorded. The percent of peak current inhibited by baclofen (Fig.
5B) was greater in the presence of nimodipine (49.2 ± 1.2%) than in its absence (37 ± 4%). The greater baclofen
sensitivity of Ca2+ currents after removal
of the L-type component confirms extensive evidence (Plummer et al.,
1991
; Dolphin, 1995
) that L-type VSCCs are generally insensitive to
membrane-delimited G-protein-mediated inhibition.
G-protein-coupled inhibition of Ca2+ channel
current with age in culture
The effects of baclofen on sister cultures were investigated as
above at 7 (n = 12), 14 (n = 12), and
21 (n = 11) DIV. Baclofen-sensitive Ca2+ channel current declined
significantly between 7 and 21 DIV (Fig. 6A). Furthermore, when
corrected for cell size, the absolute current density (Fig.
6B, left) and the percent of peak current
density (Fig. 6B, right) that were
baclofen-sensitive decreased substantially with age in culture (Fig.
6B) (p < 0.005, ANOVA). Only
~2 pA/pF was sensitive to baclofen by 21 DIV, or ~10% of total
current density, in comparison with nearly 6 pA/pF (40%) at 7 DIV
(Fig. 6B). To assess whether the decline in baclofen
sensitivity is simply a reflection of the relative decrease
in N-type current, the N-type peak current density is replotted (from
Fig. 3B) side-by-side with baclofen-inhibited current in
Figure 6B for comparison purposes. These comparisons
show clearly that the decrease in G-protein-coupled inhibition from 7 to 21 DIV is much greater than could be accounted for simply by a
decrease in the amount or fraction of G-protein-sensitive N-type
current (or P/Q + R type; e.g., Fig. 3B). Therefore, the decrease in baclofen-sensitive current reflects a reduction of inhibitory regulation of Ca2+ current
that, at least on the surface, is separate from the shift in relative
density.

View larger version (31K):
[in this window]
[in a new window]
|
Figure 6.
Decline in baclofen-sensitive current
with age in culture. A, Averaged waveforms from 7 (n = 12), 14 (n = 11), and 21 (n = 10) DIV neurons before and after 100 µM baclofen application. Baclofen significantly inhibited
current in all groups (two-way ANOVA RM; *post hoc
Tukey's comparison, p < 0.05). B,
Baclofen-sensitive current density was significantly reduced with age
in culture (one-way ANOVA, p < 0.001). To
facilitate comparison with previous data, N-type peak current density
(gray bars) from Figure 3B is
replotted.
|
|
To determine whether the decreased inhibition reflected changes at
sites at/or preceding receptor-G-protein interactions (e.g., possible
reduced concentrations of functional receptors or altered receptor-G-protein coupling) rather than at
G-protein-Ca2+ channel interactions, cells were recorded
at 7 and 21 DIV with pipettes containing 0.5 mM GTP or
guanosine 5'-3-O-(thio)triphosphate (GTP
S, a
nonhydrolyzable analog of GTP that irreversibly activates G-proteins).
Use of GTP
S effectively circumvents receptors and receptor-G-protein coupling for G-protein-mediated effects.
GTP
S significantly reduced peak current density in 7 DIV but not in
21 DIV neurons (Fig. 7,
bottom, left). The percent of total current
density inhibited was reduced from 59% (7 DIV) to 24% (21 DIV) (Fig.
7, bottom, right). Thus, the primary site of declining G-protein-coupled inhibition of VSCCs appears to lie at or
after the G-protein-channel interaction process.

View larger version (24K):
[in this window]
[in a new window]
|
Figure 7.
GTP S-sensitive current decreases with age in
culture. Top, Averaged whole-cell current from control
and GTP S-treated cells at 7 and 21 DIV (n = 8-9
per group). Bottom, Peak current density
(left) and percent of control peak current
(right) inhibited by intracellular GTP S both
demonstrate a significant inhibition of current by GTP S in 7 but not
21 DIV cultured cells (p < 0.05; two-way
ANOVA). To facilitate comparisons with Figure 6, the amount and percent
of current inhibited was calculated relative to the mean of the
untreated control group.
|
|
 |
DISCUSSION |
The two major new findings in this study are that in primary
hippocampal neurons (1) L-type current density appears to be the only
type of high-threshold VSCC current density that increases substantially with age after 7 DIV; and (2) increased influx of Ca2+ through non-L-VSCCs may nevertheless
develop with age after 7 DIV. This latter effect can occur through the
novel age-dependent mechanism of declining neurotransmitter-mediated,
G-protein-coupled inhibition of VSCCs. Interestingly, over the same
time frame, age-dependent increases in the vulnerability of cultured
neurons to excitotoxic insult (Choi, 1987
; Geddes et al., 1997
;
McDonald et al., 1997
; Adamec et al., 1998
) and increased concomitant
Ca2+ transients have been reported
(Thibault et al., 1997
). Furthermore, we recently observed that
nimodipine inhibits age-dependent, spontaneous cell death in cultured
hippocampal neurons (Porter et al., 1997
), suggesting that the present
findings of a selective increase in L-type current with age in culture
may have major implications for the role of VSCCs in cell death and excitotoxicity.
Age-dependent alterations in VSCC current density
The present studies confirmed previous findings of an
age-dependent increase in L-type current density in primary cultures of
hippocampal neurons (Porter et al., 1997
) and extended this observation
here to show that after 7 DIV a similar increase does not occur in
other high-threshold VSCC types. When current amplitudes were
normalized for cell size, current density for the N and P/Q + R
components increased only during the first week of culture. In
contrast, the late L-type component continued to rise substantially through 21 DIV, resulting in a nearly twofold increase at 21 DIV compared with 7 DIV. This pattern occurred only in the late current component. For peak current, which was dominated by the P/Q + R
component after 3 DIV, all components remained relatively stable after
7 DIV. However, it should perhaps be noted that the L-type contribution
to peak current could have been partially masked. Nimodipine block of
L-VSCCs is voltage-dependent and delayed in onset during a depolarizing
step (Bean, 1984
; Ertel and Cohen, 1994
). This could lead to
underestimating its contribution to the rapid peak. Nevertheless, the
only clear increase in any component of current density between 7 and
21 DIV, which is the period of maximal increase in excitotoxic
vulnerability, occurred in the late component of L-VSCC current density
(Fig. 3).
Aging-related increases have been found in mRNA for the
1D (and possibly the
1C) subunit of the L-VSCC (with no change in
1b subunit mRNA), and accompany the
age-related increases in L-type channel density both in
vitro (Porter et al., 1997
) and in vivo (Thibault and
Landfield, 1996
; Herman et al., 1998
). This suggests that selectively
enhanced gene expression, perhaps resulting from an accelerated aging
or developmental genomic program, could underlie some aspects of
the shift in VSCC current density. Alternatively, the enhanced
expression might be a response to cellular stimuli signaling declining
neuronal viability, perhaps somewhat analogous to the selective changes
in gene expression seen on a shorter time scale after injury (Kelley
and Steward, 1997
).
G-protein-coupled inhibition of non-L-type Ca2+
channel current
Excitatory as well as inhibitory neurotransmitters can trigger
G-protein-coupled inhibition of VSCCs (see introductory remarks). Glutamate, for example, has been found to inhibit N- and P-type VSCCs
through metabotropic glutamate receptors (mGluRs) in several neuronal
types (Sahara and Westbrook, 1993
; Hay and Kunze 1994
; Choi and
Lovinger, 1996
; Stefani et al., 1998
). However, excitatory neurotransmitters, such as glutamate, also induce major postsynaptic Ca2+ influx, both directly through their
own ionotropic receptors and indirectly, through depolarization of
VSCCs (Brown and Jaffe, 1994
; Magee and Johnston, 1995
; Bollmann et
al., 1998
). Consequently, the mGluR-mediated inhibition of VSCCs
appears to act in some ways as a negative feedback mechanism to
regulate Ca2+ elevation.
Moreover, although they are present postsynaptically, non-L-VSCCs have
also been widely implicated in presynaptic
Ca2+-dependent transmitter release
(Wheeler et al., 1994
; Wu and Saggau, 1994
; Magee and Johnston, 1995
;
Scholz and Mitter, 1995
; Mochida et al., 1996
; Wu et al., 1998
).
Therefore, impaired G-protein inhibition of presynaptic VSCC would lead
to enhanced transmitter release from either inhibitory or excitatory
terminals. In the case of glutamatergic terminals, this could be
particularly relevant to age-dependent changes in excitotoxic
vulnerability. Several types of mGluR receptors are localized
presynaptically and appear to act in part by reducing glutamate release
(Conn et al., 1998
; Moroni et al., 1998
). Thus, the age-dependent
decline in G-protein-coupled inhibition of VSCCs seen here would likely
result in greater presynaptic Ca2+ influx
at glutamatergic terminals, which, in turn, could contribute to greater
release and heightened excitotoxicity.
The decline in G-protein inhibition was not accounted for simply by a
relative decrease in G-protein-sensitive N or P/Q + R type VSCCs (Figs.
3B, 6), indicating that the specific coupling pathway was
somehow altered. There are multiple mechanisms through which G-protein
regulation could be altered with age (Beech et al., 1992
; Luebke and
Dunlap, 1994
; Rhim et al., 1996
). In the present studies,
baclofen-mediated Ca2+ channel current
inhibition met several criteria (e.g., PTX sensitivity and kinetic
slowing) that indicate a membrane-delimited,
Gi/o-protein-coupled inhibition (Cox and Dunlap,
1992
; Boland and Bean, 1993
; Hille, 1994
).
Membrane-delimited inhibition of N and P/Q + R type VSCCs appears to
depend on an interaction of the G
heterodimer with the
1 subunit of the
Ca2+ channel (Herlitze et al., 1996
;
Ikeda, 1996
; Zamponi and Snutch, 1998
), possibly in competition with
the VSCC
subunit (Bourinet et al., 1996
; Qin et al., 1997
; Roche
and Treistman, 1998
). In the present studies, the clear similarity of
the age reduction in GTP
S-sensitive current over age (Fig. 7) to the
reduction of baclofen-sensitive current (Fig. 6) indicates that the
primary deficit is probably downstream of the receptor-G-protein
coupling stage, possibly involving the coupling of
G
and the VSCC
1
subunit (Qin et al., 1997
; Zamponi and Snutch, 1998
). Although this
coupling mechanism seems unlikely to be influenced by the concomitant
increase in L-type channel membrane density, some form of
density-dependent cell surface redistribution of non-L-VSCCs away from
G-proteins cannot be ruled out.
Long-term culture as a potential model system for
aging-like changes
The long-term culture model and the in vivo brain
obviously age over very different time scales and life cycles, and the
culture system clearly cannot be viewed simply as "aging in a
dish." As noted, however, the long-term culture shows several
patterns of age-dependent increase in Ca2+
channel currents, L-VSCC membrane density, and
1D mRNA expression (Porter et al., 1997
),
among other variables, that are remarkably similar in pattern to
increases found during aging in vivo (Landfield et al.,
1989
; Moyer et al., 1992
; Disterhoft et al., 1994
; Campbell et al.,
1996
; Thibault and Landfield, 1996
; Herman et al., 1998
). It seems
possible, therefore, that selective gene expression or some other
aspects of in vivo aging might be accelerated and expressed much earlier in vitro than in vivo, perhaps
because of differences in the environmental milieu of growth and
inhibitory factors, and/or reduced contact inhibition. At the least,
the in vitro culture model may be of considerable value for
studying the relationship between time-dependent changes in
Ca2+-regulating mechanisms and altered
neuronal vulnerability.
The finding here that a G-protein-coupled process declines with age
appears to further strengthen this culture model for aging studies,
because a decline in some G-protein-coupled responses (e.g.,
G
subunit-activated processes), has been
observed in brain aging and Alzheimer's disease (Wang et al., 1992
;
Roth et al., 1995
; Cowburn et al., 1996
). Although the
membrane-delimited (G
-mediated) pathway has
not yet been studied in aging animals, the present results suggest the
intriguing hypothesis, and testable prediction, that a deficit in this
pathway will also be found in the neurons of aged animals.
Functional implications
The present studies have identified selective and novel
age-dependent mechanisms through which
Ca2+ influx through both L-type and
non-L-type VSCCs can be increased in neurons. These findings raise the
possibility that separate Ca2+ influx
pathways could act together to alter function or vulnerability with
age. On the other hand, the functional consequences of increased Ca2+ influx through these separate
pathways could be very different, because it is becoming increasingly
evident that dissimilar routes of Ca2+
influx can have substantially different effects (Tymianski et al.,
1993
; Gallin and Greenberg, 1995
; Bito et al., 1997
; Bollmann et al.,
1998
). Influx through L-type VSCCs, for example, appears to be
considerably more effective at inducing gene expression than influx
through other ligand- and other voltage-gated
Ca2+ channels (Gallin and Greenberg, 1995
;
Bito et al., 1997
).
As noted above, one other major difference in these influx pathways is
that, unlike L-VSCCs, non-L-VSCCs can also regulate presynaptic release
during neurotransmission. Thus, decreased G-protein-mediated inhibition
of non-L-VSCCs presynaptically could result in elevated (and
disruptive) release of multiple transmitters, including glutamate. The
latter, in turn, could be one factor in enhanced vulnerability with age
in culture.
 |
FOOTNOTES |
Received May 14, 1999; revised July 19, 1999; accepted July 20, 1999.
This work was supported in part by grants National Institute on Aging
Grants AG04542 and AG10836. We thank Elsie Barr, Jann Geddes, and
Veronique Thibault for important technical assistance and Kelley
Secrest for excellent assistance with this manuscript.
Correspondence should be addressed to Dr. Eric M. Blalock, Department
of Pharmacology, MS-310 UKMC, University of Kentucky, Lexington, KY
40536-0298.
 |
REFERENCES |
-
Abele AE,
Scholz KP,
Scholz WK,
Miller RJ
(1990)
Excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons.
Neuron
2:413-419.
-
Adamec C,
Didier M,
Nixon RA
(1998)
Developmental regulation of the recovery process following glutamate-induced calcium rise in rodent primary neuronal cultures.
Brain Res Dev Brain Res
108:101-110[Medline].
-
Ankarcrona M,
Dypbukt JM,
Bonfoco E,
Zhitovsky E,
Orrenius S,
Lipton SA,
Nicotera P
(1995)
Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.
Neuron
15:961-973[ISI][Medline].
-
Armitage P,
Berry G
(1990)
In: Statistical methods in scientific research. Boston: Blackwell Scientific.
-
Armstrong CM,
Gilly WF
(1992)
Access resistance and space-clamp problems associated with whole-cell patch clamping.
Methods Enzymol
207:100-122[ISI][Medline].
-
Banker GA,
Cowan WM
(1977)
Rat hippocampal neurons in dispersed cell culture.
Brain Res
126:397-342[ISI][Medline].
-
Bargas J,
Howe A,
Eberwine J,
Cao Y,
Surmeier DJ
(1994)
Cellular and molecular characterization of Ca2+ channel currents in acutely isolated, adult rat neostriatal neurons.
J Neurosci
14:6667-6686[Abstract].
-
Barnes CA
(1994)
Normal aging: regionally specific changes in hippocampal synaptic transmission.
Trends Neurosci
17:13-18[ISI][Medline].
-
Barnes CA,
McNaughton BL
(1980)
Physiological compensation for loss of afferent synapses in rat hippocampal granule cells during senescence.
J Physiol (Lond)
309:473-485[Abstract/Free Full Text].
-
Basarsky TA,
Parpura V,
Haydon PG
(1994)
Hippocampal synaptogenesis in cell culture: developmental time course of synapse formation, calcium influx, and synaptic protein distribution.
J Neurosci
14:6402-6411[Abstract].
-
Bean BP
(1984)
Nitrendipine block of cardiac calcium channels: high affinity binding to the inactivated state.
Proc Natl Acad Sci USA
81:6388-6392[Abstract/Free Full Text].
-
Bean BP
(1989)
Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence.
Nature
340:153-156[Medline].
-
Beech DJ,
Bernheim L,
Hille B
(1992)
Pertussis toxin and voltage-dependence distinguish multiple pathways modulating calcium channels of sympathetic neurons.
Neuron
8:97-106[ISI][Medline].
-
Bickford-Wimer PC,
Miller JA,
Freedman R,
Rose GM
(1988)
Age-related reduction in responses of rat hippocampal neurons to locally applied monoamines.
Neurobiol Aging
9:173-179[ISI][Medline].
-
Birnbaumer L,
Campbell KP,
Catterall WA,
Harpold MM,
Hofmann F,
Horne WA,
Mori Y,
Schwartz A,
Snutch TP,
Tanabe T,
Tsien RW
(1994)
The naming of voltage-gated calcium channels.
Neuron
13:505-506[ISI][Medline].
-
Bito H,
Deisseroth K,
Tsien RW
(1997)
Ca2+-dependent regulation in neuronal gene expression.
Curr Opin Neurobiol
7:419-429[ISI][Medline].
-
Boland LM,
Bean BP
(1993)
Modulation of N-type calcium channels in bullfrog sympathetic neurons by luteinizing hormone-releasing hormone: kinetics and voltage dependence.
J Neurosci
13:516-533[Abstract].
-
Boland LM,
Morrill JA,
Bean BP
(1994)
-Conotoxin block of calcium channels in frog and rat sympathetic neurons.
J Neurosci
14:5011-5027[Abstract]. -
Bollmann JH,
Helmchen F,
Borst JGG,
Sakmann B
(1998)
Postsynaptic Ca2+ influx mediated by three different pathways during synaptic transmission at a calyx-type synapse.
J Neurosci
18:10409-10419[Abstract/Free Full Text].
-
Bourinet E,
Soong TW,
Stea A,
Snutch TP
(1996)
Determinants of the G-protein dependent opioid modulation of neuronal calcium channels.
Proc Natl Acad Sci USA
93:1486-1491[Abstract/Free Full Text].
-
Brown TH,
Jaffe DB
(1994)
Calcium imaging in hippocampal neurons using confocal microscopy.
In: Calcium hypothesis of aging and dementia, Annals of the New York Academy of Sciences, Vol 747 (Disterhoft JF,
Gispen WH,
Traber J,
Khachaturian ZS,
eds), pp 313-324. New York: NewYork Academy of Sciences.
-
Cahalan M,
Neher E
(1992)
Patch-clamp techniques: an overview.
Methods Enzymol
207:3-14[ISI][Medline].
-
Campbell LW,
Hao SY,
Thibault O,
Blalock EM,
Landfield PW
(1996)
Aging changes in voltage-gated calcium currents in hippocampal CA1 neurons.
J Neurosci
16:6286-6295[Abstract/Free Full Text].
-
Carnevale NT,
Tsai KY,
Claiborne BJ,
Brown TH
(1997)
Comparative electrotonic analysis of three classes of rat hippocampal neurons.
J Neurophysiol
78:703-720[Abstract/Free Full Text].
-
Catterall WA
(1995)
Structure and function of voltage-gated ion channels.
Annu Rev Biochem
64:493-531[ISI][Medline].
-
Choi DW
(1987)
Ionic dependence of glutamate neurotoxicity in cortical cell culture.
J Neurosci
7:369-379[Abstract].
-
Choi DW
(1988)
Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage.
Trends Neurosci
11:465-469[ISI][Medline].
-
Choi DW,
Lovinger DM
(1996)
Metabotropic glutamate receptor modulation of voltage-gated Ca2+ channels involves multiple receptor subtypes in cortical neurons.
J Neurosci
16:36-45[Abstract/Free Full Text].
-
Conn PJ,
Bradley SR,
Macek TA,
Winder DG,
Gereau RW
(1998)
Physiological roles of multiple metabotropic glutamate receptor subtypes in the hippocampus.
In: Metabotropic glutamate receptors and brain function (Moroni R,
Nicoletti F,
Pellegrini-Giampietro DE,
eds), pp 87-98. Miami: Portland.
-
Cowburn RF,
Fowler CJ,
O'Neill C
(1996)
Neurotransmitter receptor/G-protein mediated signal transduction in Alzheimer's disease brain.
Neurodegeneration
5:483-488[Medline].
-
Cox DH,
Dunlap K
(1992)
Pharmacologic discrimination of N-type from L-type calcium current and its selective modulation by transmitters.
J Neurosci
12:906-914[Abstract].
-
Currie KP,
Fox AP
(1997)
Comparison of N- and P/Q-type voltage-gated calcium channel current inhibition.
J Neurosci
17:4570-4579[Abstract/Free Full Text].
-
Delcour A,
Tsien RW
(1993)
Altered prevalence of gating in neurotransmitter inhibition of N-type calcium channels.
Science
259:980-984[Abstract].
-
Diochet S,
Richard S,
Baldy-Moulinier M,
Nargeot J,
Valmier J
(1995)
Dihydropyridines, phenylalkylamines and benzothiazepines block N-, P/Q-, and R-type calcium currents.
Pflügers Arch
431:10-19[ISI][Medline].
-
Disterhoft JF,
Moyer JR,
Thompson LT
(1994)
The calcium rationale in aging and Alzheimer's disease: evidence from an animal model of normal aging.
In: Calcium hypothesis of aging and dementia, Annals of the New York Academy of Sciences, Vol 747 (Disterhoft JF,
Gispen WH,
Traber J,
Khachaturian ZS,
eds), pp 382-406. New York: New York Academy of Sciences.
-
Dolphin AC
(1995)
Voltage-dependent calcium channels and their modulation by neurotransmitters and G proteins.
Exp Physiol
80:1-36[ISI][Medline].
-
Dubinsky JM,
Rothman SM
(1991)
Intracellular calcium concentrations during "chemical hypoxia" and excitotoxic neuronal injury.
J Neurosci
11:2545-2551[Abstract].
-
Dutar P,
Nicoll RA
(1988)
A physiologic role for GABAB receptors in the central nervous system.
Nature
332:156-158[Medline].
-
Eliot LS,
Johnston D
(1994)
Multiple components of calcium current in acutely dissociated dentate gyrus granule neurons.
J Neurophysiol
72:762-777[Abstract/Free Full Text].
-
Ertel EA,
Cohen CJ
(1994)
Voltage-dependent interactions: the influence and significance of membrane potential on drug receptor interactions.
Drug Dev Res
33:203-213.
-
Fisher RE,
Gray R,
Johnston D
(1990)
Properties and distribution of single voltage-gated calcium channels in adult hippocampal neurons.
J Neurophysiol
64:91-104[Abstract/Free Full Text].
-
Forti L,
Pietrobon D
(1993)
Functional diversity of L-type calcium channels in rat cerebellar neurons.
Neuron
10:437-450[ISI][Medline].
-
Frandsen A,
Schousboe A
(1990)
Development of excitatory amino acid induced cytotoxicity in cultured neurons.
Int J Dev Neurosci
8:209-216[ISI][Medline].
-
Frank C,
Engert F,
Tokutomi N,
Lux HD
(1996)
Different effects of baclofen and GTP
S on voltage-activated Ca2+ currents in rat hippocampal neurons in vitro.
Eur J Pharmacol
295:87-92[ISI][Medline]. -
Gallin WJ,
Greenberg ME
(1995)
Calcium regulation of gene expression in neurons: the mode of entry matters.
Curr Opin Neurobiol
5:367-374